16697-49-7

Basic information

• Product Name: 3,4,6-Tri-O-benzyl-beta-D-mannopyranose-1,2-(methyl orthoacetate)
• Synonyms: 3,4,6-Tri-O-benzyl--D-mannopyranose 1,2-(Methyl Orthoacetate);3,4,6-Tri-O-benzyl-beta-D-mannopyranose-1,2-(methyl orthoacetate);1,2-O-(1-Methoxyethylidene)-3,4,6-tris-O-(phenylMethyl)-β-D-Mannopyranose;3,4,6-Tri-O-benzyl-1,2-O-(1-methoxyethylidene)-beta-D-mannopyranose min. 98%;β-D-Mannopyranose, 1,2-O-(1-Methoxyethylidene)-3,4,6-tris-O-(phenylMethyl)-
• CAS NO: 16697-49-7
• Molecular Formula: C₃₀H₃₄O₇
• Molecular Weight: 506.592
• Product Categories: Carbohydrates & Derivatives;Aromatics
• Mol File: 16697-49-7.mol
• Article Data: 29

Chemical Properties

• Melting Point: 74-76°C
• Boiling Point: 601.108 °C at 760 mmHg
• Flash Point: 232.122 °C
• Appearance: White Solid
• Density: 1.228 g/cm³
• Refractive Index: 1.593
• Storage Temp.: Refrigerator
• Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
• CAS DataBase Reference: 3,4,6-Tri-O-benzyl-beta-D-mannopyranose-1,2-(methyl orthoacetate)(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4,6-Tri-O-benzyl-beta-D-mannopyranose-1,2-(methyl orthoacetate)(16697-49-7)
• EPA Substance Registry System: 3,4,6-Tri-O-benzyl-beta-D-mannopyranose-1,2-(methyl orthoacetate)(16697-49-7)

Safety Data

• Hazardous Substances Data: 16697-49-7(Hazardous Substances Data)

Usage

Description

3,4,6-Tri-O-benzyl-β-D-mannopyranose 1,2-(methyl orthoacetate) is a synthetic intermediate used in glycosylation reactions. Typically, the methyl orthoester protecting group is first removed by mild acid hydrolysis, producing a glycosyl donor. Removal of the O-benzyl protecting groups is performed late in the synthesis.

Chemical Properties

White Solid

Uses

3,4,6-Tri-O-benzyl-β-D-mannopyranose 1,2-(Methyl Orthoacetate) (cas# 16697-49-7) is a compound useful in organic synthesis.

InChI:InChI=1/C30H34O7/c1-30(31-2)36-28-27(34-20-24-16-10-5-11-17-24)26(33-19-23-14-8-4-9-15-23)25(35-29(28)37-30)21-32-18-22-12-6-3-7-13-22/h3-17,25-29H,18-21H2,1-2H3/t25?,26-,27+,28-,29+,30?/m1/s1

Upstream product

• 100-39-0 benzyl bromide 
• 29073-91-4 1,2-O-(1-methoxyethylidene)-β-D-mannopyranose 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 3254-16-8 3,4,6-tri-O-acetyl-[1,2-O-(1-methoxyethylidene)]-α-D-glucopyranose 
• 100-44-7 benzyl chloride 
• 3254-16-8 3,4,6-tri-O-acetyl-1,2-O-(1-methoxyethylidene)-β-D-mannopyranose 
• 3947-62-4 2,3,4,5-tetra-O-acetyl-D-glucopyranose 
• 67-56-1 methanol 
• 13242-53-0 acetobromomannose 
• 83-87-4 D-Mannose pentaacetate 
• 572-09-8 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
• 83-87-4 D-glucose pentaacetate 
• 572-09-8 2,3,4,6-tetra-O-acetyl-D-glucopyranosyl bromide 
• 29073-91-4 (3aR,5R,6S,7S,7aR)-5-Hydroxymethyl-2-methoxy-2-methyl-tetrahydro-[1,3]dioxolo[4,5-b]pyran-6,7-diol 

Downstream Products

• 117703-05-6 6-(N-benzyloxycarbonylamino)-hexyl-2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranoside 
• 20672-69-9 methyl 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranoside 
• 129214-38-6 2-O-acetyl-3,4,6-tri-O-benzyl-D-mannopyranoside 
• 93381-69-2 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl bromide 
• 69435-20-7 C₅₀H₆₂O₉ 
• 79218-68-1 2-O-acetyl-3,4,6-tri-O-benzyl-D-glucopyranose 
• 68567-54-4 1,2-di-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranoside 
• 65827-57-8 1,2,6-tri-O-acetyl-3,4-di-O-benzyl-α-D-mannopyranose 
• 138181-67-6 phenyl 2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside 
• 138925-14-1 phenyl 2-O-acetyl-3,4,6-tri-O-benzyl-β-D-glucopyranoside 
• 911291-36-6 3,4,6-tri-O-benzyl-β-D-mannopyranose 
• 65827-56-7 3,4,6-Tri-O-benzyl-D-mannose 
• 152871-96-0 phenyl 1-deoxy-2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside 
• 197158-97-7 benzothiazol-2-yl 2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside 

Relevant articles and documents

Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and in Vitro Evaluation of the Entire Positional Isomer Library of ortho-Carboranylmethyl-Bearing Glucoconjugates

Boron neutron capture therapy (BNCT) is a noninvasive binary therapeutic modality applicable to the treatment of cancers. While BNCT offers a tumor-targeting selectivity that is difficult to match by other means, the last obstacles preventing the full har

Total Synthesis of Tri-, Hexa- and Heptasaccharidic Substructures of the O-Polysaccharide of Providencia rustigianii O34

A general and efficient strategy for synthesis of tri-, hexa- and heptasaccharidic substructures of the lipopolysaccharide of Providencia rustigianii O34 is described. For the heptasaccharide seven different building blocks were employed. Special features of the structures are an α-linked galactosamine and the two embedded α-fucose units, which are either branched at positions-3 and -4 or further linked at their 2-position. Convergent strategies focused on [4+3], [3+4], and [4+2+1] couplings. Whereas the [4+3] and [3+4] coupling strategies failed the [4+2+1] strategy was successful. As monosaccharidic building blocks trichloroacetimidates and phosphates were employed. Global deprotection of the fully protected structures was achieved by Birch reaction.

A Concise Synthesis of Oligosaccharides Derived From Lipoarabinomannan (LAM) with Glycosyl Donors Having a Nonparticipating Group at C2

Mycobacteria infection resulting in tuberculosis (TB) is one of the top ten leading causes of death over the world, and lipoarabinomannan (LAM) has been confirmed to play significant roles in this process. In this study, a convenient synthetic approach ha